Track Quest Diagnostics Incorporated — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Quest Diagnostics Incorporated DGX · Stock Open Quest Diagnostics Incorporated in new tab

259.60 USD
P/E
25.86
EPS
10.04
Yield
1.33%
Safety Score
96
P/B
3.74
ROE
15.32
Beta
0.55
Target Price
257.27 USD
Quest Diagnostics Incorporated logo

Quest Diagnostics Incorporated

🧾 Earnings Recap – Q3 2026

Quest reported 10% revenue growth and raised its full-year revenue and EPS guidance; with the stock up 1.8%, the reaction was modest rather than a clear endorsement. The transcript cites broad channel growth and productivity gains, though the excerpt does not provide the revised guidance figures.

  • Revenue grew 10% and adjusted EPS increased more than 15% in the quarter.
  • Physician-channel revenue grew at a high-single-digit rate; hospital revenue grew by double digits, while reference testing revenue was up mid-single digits.
  • Quest expects consumer-health growth to exceed 30% for the full year and plans to launch Apple Health app lab ordering later this year.
  • Key advanced diagnostic tests, including in cardiometabolic, hormone, and Alzheimer’s disease areas, grew by double digits.
  • The company said it remains on track to deliver 3% in annual cost savings and productivity improvements through Invigora.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 9, 2027
P/E25.86
EPS10.04
Book Value69.38
Price to Book3.74
Debt/Equity79.65
% Insiders0.860%
Growth
Revenue Growth0.10%
Earnings Growth0.29%
Estimates
Forward P/E21.67
Forward EPS11.98
Target Mean Price257.27
Dividend
Dividend Yield1.33%
Annual dividends3.38 USD
Ex-Div. DateJan. 12, 2027
Payout32.68%
5y avg Yield1.87%

DCF valuation

Model fair value for Quest Diagnostics Incorporated (DGX)
Result
Sign in to run the valuation for DGX.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
15 analysts · consensus Buy · mean target 257.27 USD (low 235.00, high 279.00) · as of 15 Nov 2026
Low 235.00
Mean 257.27
High 279.00
Price 259.60
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Quest Diagnostics Incorporated Logo Quest Diagnostics Incorporated Analysis (DGX)

United States Health Care Official Website Stock

Is Quest Diagnostics Incorporated a good investment? Quest Diagnostics Incorporated (DGX) is currently trading at 259.60 USD. Market analysts have a consensus price target of 257.27 USD. This suggests the asset is currently trading above analyst expectations.

In terms of valuation, the stock trades at a P/E ratio of 25.86. This valuation is generally in line with the broader market.

Earnings Schedule: Quest Diagnostics Incorporated is expected to release its next earnings report on Feb. 9, 2027. The market consensus estimate for Forward EPS is 11.98.

For income investors, Quest Diagnostics Incorporated pays a dividend yield of 1.33%. With a payout ratio of 33%, the dividend appears sustainable.

Investor FAQ

Does Quest Diagnostics Incorporated pay a dividend?

Yes, it pays an annual dividend of 3.38 USD (1.33% yield).

What asset class is Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated is classified as a Stock. You can compare it against 5 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 9, 2027. The company currently has a trailing EPS of 10.04.

Company Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Exchange Ticker
MEX (Mexico) DGX.MX
NYQ (United States) DGX
FRA (Germany) QDI.F
SAO (Brazil) Q1UE34.SA
GER (Germany) QDI.DE
Trades
Dividend Yield
1.33%
5y avg 1.87%
Annual Dividends
3.38USD
Next Ex. Div Date
Jan. 12, 2027
Payout Ratio
32.68%
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2027
3.64 USD
Oct. 21, 2027 (estimated) 0.9253
July 22, 2027 (estimated) 0.9253
April 20, 2027 (estimated) 0.9253
Jan. 27, 2027 0.8600
▸2026
3.38 USD
Oct. 21, 2026 0.8600
July 22, 2026 0.8600
April 20, 2026 0.8600
Jan. 28, 2026 0.8000
▸2025
3.15 USD
Oct. 20, 2025 0.8000
July 21, 2025 0.8000
April 21, 2025 0.8000
Jan. 29, 2025 0.7500
▸2024
2.96 USD
Oct. 21, 2024 0.7500
July 22, 2024 0.7500
April 22, 2024 0.7500
Jan. 31, 2024 0.7100
▸2023
2.79 USD
Oct. 23, 2023 0.7100
July 25, 2023 0.7100
April 24, 2023 0.7100
Feb. 1, 2023 0.6600
▸2022
2.60 USD
Oct. 19, 2022 0.6600
July 20, 2022 0.6600
April 20, 2022 0.6600
Feb. 2, 2022 0.6200
▸2021
2.42 USD
Oct. 20, 2021 0.6200
July 21, 2021 0.6200
April 21, 2021 0.6200
Feb. 3, 2021 0.5600
▸2020
2.21 USD
Oct. 21, 2020 0.5600
July 22, 2020 0.5600
April 21, 2020 0.5600
Jan. 29, 2020 0.5300
▸2019
2.12 USD
Oct. 21, 2019 0.5300
July 22, 2019 0.5300
April 22, 2019 0.5300
Jan. 30, 2019 0.5300
▸2018
1.95 USD
Oct. 22, 2018 0.5000
July 23, 2018 0.5000
April 18, 2018 0.5000
Jan. 24, 2018 0.4500
▸2017
1.80 USD
Oct. 18, 2017 0.4500
July 24, 2017 0.4500
April 19, 2017 0.4500
Jan. 25, 2017 0.4500
▸2016
1.58 USD
Oct. 19, 2016 0.4000
July 20, 2016 0.4000
April 20, 2016 0.4000
Jan. 27, 2016 0.3800
▸2015
1.47 USD
Oct. 21, 2015 0.3800
July 22, 2015 0.3800
April 22, 2015 0.3800
Jan. 28, 2015 0.3300
▸2014
1.29 USD
Oct. 22, 2014 0.3300
July 23, 2014 0.3300
April 23, 2014 0.3300
Jan. 22, 2014 0.3000
▸2013
1.20 USD
Oct. 16, 2013 0.3000
July 17, 2013 0.3000
April 16, 2013 0.3000
Jan. 28, 2013 0.3000
▸2012
0.68 USD
Oct. 16, 2012 0.1700
July 18, 2012 0.1700
April 17, 2012 0.1700
Jan. 24, 2012 0.1700
▸2011
0.40 USD
Oct. 24, 2011 0.1000
July 19, 2011 0.1000
April 19, 2011 0.1000
Jan. 25, 2011 0.1000
▸2010
0.40 USD
Oct. 19, 2010 0.1000
July 20, 2010 0.1000
April 20, 2010 0.1000
Jan. 22, 2010 0.1000
▸2009
0.40 USD
Oct. 19, 2009 0.1000
July 20, 2009 0.1000
April 20, 2009 0.1000
Jan. 26, 2009 0.1000
▸2008
0.40 USD
Oct. 20, 2008 0.1000
July 18, 2008 0.1000
April 18, 2008 0.1000
Jan. 23, 2008 0.1000
▸2007
0.40 USD
Oct. 17, 2007 0.1000
July 18, 2007 0.1000
April 18, 2007 0.1000
Jan. 24, 2007 0.1000
▸2006
0.39 USD
Oct. 18, 2006 0.1000
July 21, 2006 0.1000
April 19, 2006 0.1000
Jan. 25, 2006 0.0900
▸2005
0.51 USD
Oct. 19, 2005 0.0900
July 22, 2005 0.0900
April 20, 2005 0.1800
Jan. 26, 2005 0.1500
▸2004
0.60 USD
Oct. 22, 2004 0.1500
July 21, 2004 0.1500
April 21, 2004 0.1500
Jan. 23, 2004 0.1500
Upcoming Dividends
Name Payment Date Status Amount
Quest Diagnostics Incorporated Jan 27, 2027 Upcoming 0.86 USD
Quest Diagnostics Incorporated Oct 21, 2026 0.86 USD
Quest Diagnostics Incorporated Jul 22, 2026 0.86 USD
Quest Diagnostics Incorporated Apr 20, 2026 0.86 USD
Quest Diagnostics Incorporated Jan 28, 2026 0.8 USD
Stock Splits
Split Date Split Ratio to 1
June 1, 2001 2:1
June 21, 2005 2:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion